Medicare Patients with PAH Face High Out-of-Pocket Costs | 2024 ATS
Patients with pulmonary arterial hypertension who are covered by Medicare and are eligible for the low-income subsidy have higher out-of-pocket drug costs than those with fee-for-service Medicare, according to a new poster presented recently at the …